Download video

ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC

146 views

GU Oncology Now

1 year ago

ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC

ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC

ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC
4:38
ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC
by GU Oncology Now
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
4:39
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
by ecancer
ATLAS trial: axitinib in RCC- despite reporting no significant difference, some optimism remains
4:35
ATLAS trial: axitinib in RCC- despite reporting no significant difference, some optimism remains
by VJOncology
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
9:30
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
by ecancer
Dr Rini on a Biomarker Analysis for Pembrolizumab\/Axitinib in Advanced RCC
3:28
Dr Rini on a Biomarker Analysis for Pembrolizumab\/Axitinib in Advanced RCC
by OncLive
Final results of avelumab and axitinib in RCC in the JAVELIN Renal 101 trial
1:24
Final results of avelumab and axitinib in RCC in the JAVELIN Renal 101 trial
by VJOncology
KEYNOTE-426 study
6:58
KEYNOTE-426 study
by European Association of Urology
Precision Oncology Update from ESMO 2023
3:34
Precision Oncology Update from ESMO 2023
by COR2ED The Heart of Medical Education
INMUNOSUN-SOGUG trial: sunitinib second line metastatic RCC
1:51
INMUNOSUN-SOGUG trial: sunitinib second line metastatic RCC
by VJOncology
Dr. Rini on Pembrolizumab Plus Axitinib in RCC
1:34
Dr. Rini on Pembrolizumab Plus Axitinib in RCC
by OncLive
Real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
0:44
Real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
by VJOncology
INLYTA (axitinib)- advanced renal cell carcinoma (RCC)
2:10
INLYTA (axitinib)- advanced renal cell carcinoma (RCC)
by Pharmacy Talk USA
Updated results of axitinib and nivolumab in previously treated mRCC
0:32
Updated results of axitinib and nivolumab in previously treated mRCC
by VJOncology
ESMO 2017 - Dr. Brian Rini Updates in Genitourinary Tumors
2:42
ESMO 2017 - Dr. Brian Rini Updates in Genitourinary Tumors
by Oncology Information Group
Dr. Rini on the Efficacy of Axitinib and Pembrolizumab in RCC
1:19
Dr. Rini on the Efficacy of Axitinib and Pembrolizumab in RCC
by OncLive
Dr. McGregor on the Utility of Axitinib\/Avelumab in Advanced RCC
1:06
Dr. McGregor on the Utility of Axitinib\/Avelumab in Advanced RCC
by OncLive
Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma
2:16
Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma
by OncLive
Avelumab and axitinib for the treatment of advanced RCC
0:57
Avelumab and axitinib for the treatment of advanced RCC
by VJOncology
Dr. McGregor on Implications of the FDA Approval of Pembrolizumab\/Axitinib in RCC
2:02
Dr. McGregor on Implications of the FDA Approval of Pembrolizumab\/Axitinib in RCC
by OncLive